Company & Sponsor Intelligence

Tel-Aviv Sourasky Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting0

Completed1

Countries1

Therapeutic footprint

adhddementia_otherparkinsons

Indexed studies

NCT01502384A Longitudinal Study in 1st Degree Relatives of Parkinson's Disease (PD) Patients
parkinsons · IsraelUNKNOWN

NCT00391495Inflammation in Children With Attention-Deficit/Hyperactivity Disorder
adhd · IsraelUNKNOWN

NCT02206516Feasibility of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention Deficit Disorder (ADD).
adhd · IsraelPHASE1

NCT02495649Evaluation of Myocardial Sympathetic Denervation in Parkinson's Disease Using [18F]FDOPA
parkinsons · IsraelNA

NCT04387812Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease
parkinsons · IsraelNA

NCT00382616Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD
adhd · IsraelPHASE2

NCT00700323PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children
adhd · IsraelPHASE2

NCT04154254Applying PET/MR for Dementia Applications
dementia_other · NA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →